Islets of Hope
Fast Links to Disorders Often Associated with
Fast Click to Problems Associated with
Sheri L. Sanderson is the mother of three children, including one with gluten sensitivities. Her cookbook is the result of personal need---wanting to offer her family gluten-free meals that look and taste just as good as those she made before the change in diet. In addition to many years of... Read more
The Specific Carbohydrate Diet: a carbohydrate plan for those with IBS
Irritable bowel syndrome
We are currently working on our own article about IBS and diabetes that is informative and easy to read.
For now, we refer you to the following article cut from Wikipedia.com. It is not all that lay-friendly, but contains thorough information about IBS.
From Wikipedia, the free encyclopedia.
In medicine (gastroenterology), irritable bowel syndrome (IBS) or spastic colon is a group of functional bowel disorders which are fairly common and make up 20–50% of visits to gastroenterologists. There are three forms, dependent on which symptom predominates: diarrhea-predominant (IBS-D), constipation-predominant (IBS-C) and IBS with alternating stool pattern (IBS-A). An important new IBS subtype, post-infectious IBS (IBS-PI), is drawing much clinical investigation.
There appears to be an overlap of IBS with stress, chronic pelvic pain, fibromyalgia and various mental disorders (in a small minority). While no good explanation for this phenomenon exists, it does strengthen the view that there is a neurological and psychological component to IBS.
Hormones play a role in IBS that is not yet fully understood. Menstruation frequently triggers or exacerbates IBS symptoms (Heitkemper, 2003), while pregnancy and menopause can either worsen or improve symptoms. Hormone replacement therapy is associated with an increased risk of developing IBS (Maturitas, 2003).
In 1978 Manning et al., found, from questionaire data, that IBS sufferers reported four common symptoms. The Manning Criteria was established to distinguish organic causes for symptoms from those of IBS. In 1992 the Rome I Criteria was established by a multinational committee of specialists, which further refined the Manning Criteria. In 1998 the Rome Working Team proposed changes to the definition and diagnostic criteria for IBS to reflect new research data, and to improve clarity.
The diagnosis of Irritable Bowel Syndrome has relied on a diagnosis of exclusion. Because the symptoms of IBS share the symptoms of so many other intestinal illnesses, it sometimes takes years before a correct diagnosis is made to exclude the obvious, and not so obvious, conditions which present symptoms similar to IBS.
Physicians rely on a variety of procedures and laboratory tests to confirm a diagnosis. The Rome II Criteria, however now defines markers which allows professionals to diagnose IBS after a careful examination of a sufferers medical history and physical abdominal examination which looks for any 'red flag' symptoms.
Red Flag symptoms which are NOT typical of IBS:
According to the Rome II consensus conference of the American Gastroenterological Association and international medical societies on functional bowel disorders, the diagnosis of IBS can be made when the following criteria are fulfilled:
At least 12 weeks, which need not be consecutive, in the preceding 12 months of abdominal discomfort or pain that has 2 of 3 features:
Symptoms that cumulatively support the diagnosis of IBS
Supportive Symptoms of IBS:
Diarrhea-predominant: 1 or more of 2, 4, 6 and none of 1, 3, or 5; or: 2 or more of 2, 4, or 6 and one of 1 or 5. (3. Hard or lumpy stools do not qualify.) Constipation-predominant: 1 or more of 1, 3, 5 and none of 2, 4, or 6;or: 2 or more of 1, 3, or 5 and one of 2, 4 or 6.
The diagnosis of a functional bowel disorder always presumes the absence of a structural or biochemical explanation for the symptoms. This can be excluded via:
Initial screening only requires a history and physical exam, as well as a full blood count, electrolytes, renal function, and an erythrocyte sedimentation rate. Additional testing is done when when there is a poor response to treatment.
While these modalities may be employed to rule out other causes of abdominal symptoms, they are not necessary to make a diagnosis of IBS. Depending on local practice, many doctors avoid overdiagnosing if the history is clearly suggestive of a functional bowel disorder.
A diagnostic test for IBS via assessment of colonic/rectal hypersensitivity using a barostat is currently being discussed. However, sensitivity and specificity are not yet high enough to render the method widely applicable.
IBS is highly prevalent in the Western world, but despite the advancement of many theories, no clear cause has yet been established. Increasing prevalence in developing countries suggests some possibile links to diet and cultural factors (Gwee, 2005). Evidence of visceral hyperalgesia (increased sensitivity to noxious stimuli in the gut) includes perception of pain from distention of a rectal ballon at smaller volumes than in normal patients. However somatic sensitivity testing, such as in controlled pressure on the nails of the hand show that IBS patients have greater pain tolerance than normal patients. The association of IBS with stress is less clear, but studies have shown that there is a high likelyhood of reports of previous physical and sexual abuse in IBS patients. Socially stressful situations seem to play a role in the presence of symptoms but are not known to actually affect the underlying disease.
Onset of IBS after an episode of enteritis has been described (partially after use of antibiotics). In these cases, a prolonged immune reaction may be the cause. Patients with IBS after a viral illness may have a self limited course of only 3 to 6 months duration.
IBS is widely regarded as a conglomeration of disorders with similar symptoms but a different etiology (root cause). As with many other medical conditions, there is a lot of speculation about causes, including in the field of alternative medicine.
Stress—feeling mentally or emotionally tense, troubled, angry, or overwhelmed—stimulates colon spasms in people with IBS. The colon has a vast supply of nerves that connect it to the brain. These nerves control the normal rhythmic contractions of the colon and cause abdominal discomfort at stressful times. People often experience cramps or "butterflies" when they are nervous or upset. But with IBS, the colon can be overly responsive to even slight conflict or stress. Stress also makes the mind more tuned to the sensations that arise in the colon and makes the stressed person perceive these sensations as unpleasant (NIH, 2003).
Some evidence suggests that IBS is affected by the immune system, which fights infection in the body. The immune system is also affected by stress. For all these reasons, stress management is an important part of treatment for IBS. Stress management comprises:
One of the most important therapeutic measures is reassuring the patient that she has no fatal or otherwise threatening disease, as this is the major concern of patients seeking medical help. Dietary advice may be given and medication is an option in most forms.
Halpert et al (2006), developed and fielded a questionnaire to identify patients’ perceptions about IBS, their preferences on the type of information they need, as well as educational media and expectations from health care providers. Responses from patients with IBS revealed misperceptions about IBS developing into other conditions, including colitis, malnutrition and cancer. The survey found IBS patients were most interested in learning about foods to avoid (60 percent), causes of IBS (55 percent), medications (58 percent), coping strategies (56 percent), and psychological factors related to IBS (55 percent). The respondents indicated that they wanted their physician to be available via phone or e-mail following a visit (80 percent) and have the ability to listen (80 percent), provide hope (73 percent) and support (63 percent).
There is no evidence that digestion of food or absorption of nutrients is different in those with IBS compared to those without IBS. However, the very act of eating can provoke an over-reaction of the gastrocolic response in those with IBS due to their heightened visceral sensitivity, and this can lead to abdominal pain, diarrhea, and/or constipation. Although the exact cause of IBS is not known, there are dietary factors that appear to aggravate symptoms or make a person feel worse. While dietary factors do not cause IBS, they often aggravate symptoms.(IFFGD, 2004).
Definitive determination of dietary issues can be accomplished by testing for the physiological effects of specific foods. The ELISA food allergy panel can identify specific foods to which a patient has a reaction. Other testing can determine if there are nutritional deficiencies secondary to diet that may also play a role.
There are a number of diet changes a person with IBS can make to prevent the over-reaction of the gastrocolic reflex and lessen pain, discomfort and bowel dysfunction. Having soluble fiber foods and supplements, substituting soy or rice products for dairy, being careful with fresh fruits and vegetables that are high in insoluble fiber, and eating regular small amounts can all help to lessen the symptoms of IBS (Van Vorous 2000). Foods and beverages to be avoided or minimized include red meat, oily or fatty (and fried) products, dairy (even when there is no lactose intolerance), solid chocolate, coffee (regular and decaffeinated), alcohol, carbonated beverages (especialy those also containing sorbitol) and artificial sweeteners (Van Vorous 2000). Several of the most common dietary triggers are well-established by clinical studies at this point; research has shown that IBS patients are hypersensitive to fats, insoluble fibers, and fructose (Caldarella, 2005; Whorwell, 1994; Young Choi, 2003). It also appears that some foods are more difficult for the gut as evidenced by elevated food-specific IgG4 antibodies being present (Kumar, 2005), while others increase colonic contractions, which may be painful, due to increased visceral sensitivity in IBS sufferers (Mayer, 2004).
Medications may consist of stool softeners and laxatives in constipation-predominant, and antidiarrheals (loperamide) in diarrhea-predominant IBS for mild symptoms. The use of antispasmodic drugs (e.g. anticholinergics such as hyoscine) has not shown conclusive beneficial results due to a large number of individuals who respond to the placebo effect; however, in general, although the cause is unknown, the placebo effect remains higher than normal for sufferers of IBS for all medications.
Low dosage of tricyclic and SSRI antidepressants have shown to be the most widely prescribed medications for helping to relieve symptoms of visceral sensitivity (pain) and diarrhea or constipation respectively. Newer drugs include alosetron, a selective 5-HT3 antagonist for IBS-D, which is only available for women in the United States under a restricted access program, due to severe risks of side-effects if taken mistakenly by IBS-A or IBS-C sufferers. Cilansetron, also a selective 5-HT3 antagonist, is undergoing further clinical studies in Europe for IBS-D sufferers. In 2005, Solvay Pharmaceuticals withdrew Cilansetron from the United States regulatory approval process after receiving a "not-approvable" action letter from the FDA requesting additional clinical trials. Tegaserod, a selective 5-HT4 antagonist for IBS-C, is available for relieving IBS constipation in women and chronic idiopathic constipation. The USA FDA has issued two warnings about the serious consequences of Tegaserod. In 2005, Tegaserod was rejected as an IBS medication by the European Union; however, it is available in some other countries.
Enteric coated peppermint oil capsules have been shown to relieve IBS symptoms in adults and children (Hadley, 2005), but they are contraindicated in patients with the comorbidity of gastroesophageal reflux disease.
Brain-Gut and other
Gut-directed or gut-specific hypnotherapy or self-hypnosis is one of the most promising areas of IBS treatment. Current research shows that symptom reduction/elimination from IBS hypnotherapy can last at least five years (Gonsalkorale 2003). There is a strong brain-gut component to IBS, and cognitive therapy may improve symptoms in a proportion of patients in conjunction with antidepressants (Kennedy et al, 2005). Ongoing investigational research also involves relationships to food allergies (as measured through blood antibody analysis), poor bacterial balance and the increase of probiotics (Quigley, 2005), parasites, scar tissue that affects bowel motility, and bacterial overgrowth (Pimentel, 2000), as a cause of symptoms.
Point prevalence is 10 - 20% of the general population of Western countries with a much higher lifetime prevalence. Prevalence is similar in India, Japan and China. IBS is less common in Thailand and rural South African areas. In Western countries, but not in India or Sri Lanka, females have a greater risk of developing IBS.
Of the persons who have symptoms of IBS, only a proportion seeks medical help. However, there is not yet a predictor known for who will seek medical help and who will not.
IBS is not fatal nor is it linked to the development of other serious bowel diseases. However, due to the chronic pain, discomfort, and other symptoms, work absenteeism, social phobias, and other negative quality-of-life effects can be common in more serious cases. Individuals who find a caring primary caregiver and/or sufficient self-help options should be able to develop a successful treatment program for their symptoms and lead normal lives.
Page Updated 12/08/2005